Literature DB >> 17873339

Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications.

Sudesh Vasdev1, Vicki Gill, Pawan Singal.   

Abstract

The vascular diseases, hypertension and atherosclerosis, affect millions of individuals worldwide, and account for a large number of deaths globally. A better understanding of the mechanism of these conditions will lead to more specific and effective therapies. Hypertension and atherosclerosis are both characterized by insulin resistance, and we suggest that this plays a major role in their etiology. The cause of insulin resistance is not known, but may be a result of a combination of genetic and lifestyle factors. In insulin resistance, alterations in glucose and lipid metabolism lead to the production of excess aldehydes including glyoxal and methylglyoxal. These aldehydes react non-enzymatically with free amino and sulfhydryl groups of amino acids of proteins to form stable conjugates called advanced glycation end products (AGEs). AGEs act directly, as well as via receptors to alter the function of many intra- and extracellular proteins including antioxidant and metabolic enzymes, calcium channels, lipoproteins, and transcriptional and structural proteins. This results in endothelial dysfunction, inflammation and oxidative stress. All these changes are characteristic of hypertension and atherosclerosis. Human and animal studies have demonstrated that increased AGEs are also associated with these conditions. A pathological role for AGEs is substantiated by studies showing that therapies that attenuate insulin resistance and/or lower AGEs, are effective in decreasing oxidative stress, lowering blood pressure, and attenuating atherosclerotic vascular changes. These interventions include lipoic acid and other antioxidants, AGE breakers or soluble receptors of AGEs, and aldehyde-binding agents like cysteine. Such therapies may offer alternative specific means to treat hypertension and atherosclerosis. An adjunct therapy may be to implement lifestyle changes such as weight reduction, regular exercise, smoking cessation, and increasing dietary intake of fruits and vegetables that also decrease insulin resistance as well as oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873339     DOI: 10.1007/s12013-007-0039-0

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  23 in total

1.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

Review 2.  Risk factors preceding type 2 diabetes and cardiomyopathy.

Authors:  Shamjeet Singh; Sanjiv Dhingra; Dan D Ramdath; Sudesh Vasdev; Vicki Gill; Pawan K Singal
Journal:  J Cardiovasc Transl Res       Date:  2010-07-01       Impact factor: 4.132

Review 3.  A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.

Authors:  Shehwaz Anwar; Shifa Khan; Ahmad Almatroudi; Amjad Ali Khan; Mohammed A Alsahli; Saleh A Almatroodi; Arshad Husain Rahmani
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

4.  Disease-modifying treatments for Alzheimer's disease.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 5.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 6.  Oxidative stress in diabetes and Alzheimer's disease.

Authors:  V Prakash Reddy; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Role of the immune system in hypertension: modulation by dietary antioxidants.

Authors:  Sudesh Vasdev; Jennifer Stuckless; Vernon Richardson
Journal:  Int J Angiol       Date:  2011-12

8.  Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection.

Authors:  Sean M Sliman; Timothy D Eubank; Sainath R Kotha; M Lakshmi Kuppusamy; Shariq I Sherwani; Elizabeth Susan O'Connor Butler; Periannan Kuppusamy; Sashwati Roy; Clay B Marsh; David M Stern; Narasimham L Parinandi
Journal:  Mol Cell Biochem       Date:  2009-07-08       Impact factor: 3.396

9.  Fructose and moderately high dietary salt-induced hypertension: prevention by a combination of N-acetylcysteine and L-arginine.

Authors:  Sudesh Vasdev; Vicki D Gill; Edward Randell; Yingchun Han; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2009-09-26       Impact factor: 3.396

10.  Walking and running produce similar reductions in cause-specific disease mortality in hypertensives.

Authors:  Paul T Williams
Journal:  Hypertension       Date:  2013-08-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.